Beta-adrenergic Signaling: Complexities and Therapeutic Relevance to Heart Failure

Author(s): J. David Port

Journal Name: Current Signal Transduction Therapy

Volume 7 , Issue 2 , 2012

Become EABM
Become Reviewer
Call for Editor


Adrenergic receptor signaling and heart failure are inextricably linked. Beta-adrenergic receptors (β-ARs) serve not only as physiological modulators of heart rate and contractility, they are also primary therapeutic targets of individuals with heart failure as well as many other cardiovascular disorders. In light of these relationships, this short review will focus on the basic pharmacology distinguishing adrenergic receptor subtypes; on receptor subtype selective signaling; the molecular basis of β-AR gene expression; and, delve briefly into genetic variation of β-ARs that represents a potential basis of differential natural history of heart failure progression and that may serve as an underlying basis for therapeutic response.

Keywords: Adrenergic receptors, signaling, gene regulation, genetic variation, heart failure

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 30 April, 2012
Page: [120 - 131]
Pages: 12
DOI: 10.2174/157436212800376645
Price: $65

Article Metrics

PDF: 5